Vitamin D inhibits myometrial and leiomyoma cell proliferation in vitro

Fertility and Sterility

Volumn 91, Issue 5, 2009, Pages 1919-1925

  Bläuer, Merja ^a   Rovio, Päivi H ^b   Ylikomi, Timo ^a   Heinonen, Pentti K ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

cell growth; hypovitaminosis; in vitro; Uterine leiomyoma; vitamin D

Indexed keywords

CALCIFEDIOL; CALCITRIOL; DESMIN; SMOOTH MUSCLE ACTIN; VIMENTIN; VITAMIN D RECEPTOR;

ADULT; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEIOMYOMA; MYOMETRIUM; PRIORITY JOURNAL;

ADULT; CALCIFEDIOL; CALCITRIOL; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEIOMYOMA; MIDDLE AGED; MYOMETRIUM; RECEPTORS, CALCITRIOL; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; UTERINE NEOPLASMS;

EID: 67349189224     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.02.136     Document Type: Article

References (35)

1. Stewart E.A. Uterine fibroids. Lancet 357 (2001) 293-298
2. Farquhar C.M., and Steiner C.A. Hysterectomy rates in the United States 1990-1997. Obstet Gynecol 99 (2002) 229-234
3. Flake G.P., Andersen J., and Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 111 (2003) 1037-1054
4. Arslan A.A., Gold L.I., Mital K., Suen T.C., Belitskaya-Levy I., Tang M.S., et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod 20 (2005) 852-863
5. Shushan A., Ben-Bassat H., Mishani E., Laufer N., Klein B.Y., and Rojansky N. Inhibition of leiomyoma cell proliferation in vitro by genistein and the protein tyrosine kinase inhibitor TKS050. Fertil Steril 87 (2007) 127-135
6. McDonnel D.P., Mangelsdorf D.J., Pike J.W., Haussler M.R., and O'Malley B.W. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 235 (1987) 1214-1217
7. Baker A.R., McDonnell D.P., Hughes M., Crisp T.M., Mangelsdorf D.J., Haussler M.R., et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85 (1988) 3294-3298
8. Vienonen A., Miettinen S., Bläuer M., Martikainen P., Tomas E., Heinonen P.K., et al. Expression of nuclear receptors and cofactors in human endometrium and myometrium. J Soc Gynecol Investig 11 (2004) 104-112
9. Schwartz G.G., Wang M.H., Zang M., Singh R.K., and Siegal G.P. 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells. Cancer Epidemiol Biomarkers Prev 6 (1997) 727-732
10. Lokeshwar B.L., Schwartz G.G., Selzer M.G., Burnstein K.L., Zhuang S.H., Block N.L., et al. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,25-dihydroxyvitamin D (calcitriol) and EB1089. Cancer Epidemiol Biomarkers Prev 8 (1999) 241-248
11. Mantell D.J., Owens P.E., Bundred N.J., Mawer E.B., and Canfield A.E. 1 alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 87 (2000) 214-220
12. Ylikomi T., Laaksi I., Lou Y.R., Martikainen P., Miettinen S., Pennanen P., et al. Antiproliferative action of vitamin D. Vitam Horm 64 (2002) 357-406
13. Wang Q.M., Jones J.B., and Studzinski G.P. Cyclin-dependent kinase inhibitor p27 as a mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res 56 (1996) 264-267
14. Simboli-Campbell M., Narvaez C.J., van Weelden K., Tenniswood M., and Welsh J. Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. Breast Cancer Res Treat 42 (1997) 31-41
15. Zhuang S.H., and Burnstein K.L. Antiproliferative effect of 1 alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCap involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation. Endocrinology 139 (1998) 1197-1207
16. Hager G., Formanek M., Gedlicka C., Thurnher D., Knerer B., and Kornfehl J. 1,25(OH)2 vitamin D3 induces elevated expression of the cell cycle-regulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck. Acta Otolaryngol 121 (2001) 103-109
17. Audo I., Darjatmoko S.R., Schlamp C.L., Lokken J.M., Lindstrom M.J., Albert D.M., et al. Vitamin D analogues increase p53, p21, and apoptosis in a xenograft model of human retinoblastoma. Invest Ophthalmol Vis Sci 44 (2003) 4192-4199
18. Colston K.W., and Hansen C.M. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 9 (2002) 45-49
19. Welsh J., Simboli-Campbell M., Narvaez C.J., and Tenniswood M. Role of apoptosis in the growth inhibitory effects of vitamin D in MCF-7 cells. Adv Exp Med Biol 375 (1995) 45-52
20. Kueng W., Silber E., and Eppenberger U. Quantification of cells cultured on 96-well plates. Anal Biochem 182 (1989) 16-19
21. Lou Y.-R., Laaksi I., Syvälä H., Bläuer M., Tammela T.L.J., Ylikomi T., et al. 25-Hydroxyvitamin D3 is an active hormone in human primary prostatic stromal cells. FASEB J 18 (2004) 332-334
22. Barreto A.M., Schwarz G.G., Woodruff R., and Cramer S.D. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiol Biomarkers Prev 9 (2000) 265-270
23. Itin P.H., Pittelkow M.R., and Kumar R. Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium. Endocrinology 135 (1994) 1793-1798
24. Miettinen S., Ahonen M., Lou Y.-R., Manninen T., Tuohimaa P., Syvälä H., et al. Role of 24-hydroxylase in vitamin D3 growth response of OVCAR-3 ovarian cancer cells. Int J Cancer 108 (2004) 367-373
25. Munker R., Norman A., and Koeffler H.P. Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells. J Clin Invest 78 (1986) 424-430
26. Love-Schimenti C.D., Gibson D.F., Ratnam A.V., and Bikle D.D. Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells. Cancer Res 56 (1996) 2789-2794
27. Zehnder D., Bland R., Williams M.C., McNinch R.W., Howie A.J., Stewart P.M., et al. Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86 (2001) 888-894
28. Evans K.N., Bulmer J.N., Kilby M.D., and Hewison M. Vitamin D and placental-decidual function. J Soc Gynecol Investig 5 (2004) 263-271
29. Shushan A., Rojansky N., Laufer N., Klein B.Y., Shlomai Z., Levitzki R., et al. The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth. Hum Reprod 19 (2004) 1957-1967
30. Gillies R.J., Didier N., and Denton M. Determination of cell number in monolayer cultures. Anal Biochem 159 (1986) 109-113
31. Palmberg L., and Thyberg J. Uterine smooth muscle cells in primary culture. Alterations in fine structure, cytoskeletal organization and growth characteristics. Cell Tissue Res 246 (1986) 253-262
32. Virtanen I., Lehto V.-P., Lehtonen E., Vartio T., Stenman S., Kurki P., et al. Expression of intermediate filaments in cultured cells. J Cell Sci 50 (1981) 45-63
33. Broaddus R.R., Xie S., Hsu C.-J., Wang J., Zhang S., and Zou C. The chemopreventive agents 4-HPR snd DFMO inhibit growth and induce apoptosis in uterine leiomyomas. Am J Obstet Gynecol 190 (2004) 686-692
34. Yamada T., Nakago S., Kurachi O., Wang J., Takekida S., Matsuo H., et al. Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells. Hum Reprod 19 (2004) 815-821
35. Severino M.F., Murray M.J., Brandon D.D., Clinton G.M., Burry K.A., and Novy M. Rapid loss of estrogen and progesterone receptors in human leiomyoma and myometrial explant cultures. Mol Hum Reprod 11 (1996) 823-828